Latest News
BrightFocus-funded projects get at the root of capillary stalling in Alzheimer’s disease, which reduces brain blood flow and increases risk for dementia. Evidence from mice suggests it’s not driven by diet and obesity alone, and a targeted treatment could help.
Early research shows one can prevent loss of brain nerve cell communication in Alzheimer’s disease by blocking ‘caspase’ from making toxic amyloid-beta from APP.
The top four food groups for eye health, COVID-19 and macular degeneration, the importance of regular eye exams, how to make the most of your eye doctor appointment, potential medications for dry macular degeneration. and more are discussed in the summer edition of Macular Degeneration News.
Toll-like receptor 2 (TLR2) is revealed to be a bridge between oxidative damage and inflammation in age-related macular degeneration.
BrightFocus Foundation, a leading nonprofit funder of global research on Alzheimer’s, macular degeneration, and glaucoma, today announced 93 new research grants, a $17.8 million commitment toward ending these age-related neurodegenerative diseases.
BrightFocus Foundation, a premier private funder of vision research, today announced a request for proposals for science projects supported through its Macular Degeneration Research program.
BrightFocus Foundation, a nonprofit organization funding scientific research and promoting public awareness to end diseases of mind and sight, announced a special, free virtual presentation of the award-winning documentary LINDA RONSTADT: THE SOUND OF MY VOICE on June 4-10. The at-home movie night will feature an introduction from the film’s producer James Keach, and interviews with key scientists discussing their current research.
BrightFocus Foundation is partnering with the National Institute of Health’s (NIH’s) National Institute of Neurological Disorders and Stroke (NINDS) to fund an innovative research grant to develop retinal scans to identify early signs of vascular contributions to cognitive dementia (VCID), one of the leading causes of memory loss.
BrightFocus Foundation, a nonprofit organization funding scientific research and promoting public awareness to end Alzheimer’s, macular degeneration, and glaucoma, today announced Shawna Gottlieb and Tonya M. Matthews, PhD, as new members of its Board of Directors.
Learn how to decrease your risk of developing Alzheimer's disease, if statins increase or decrease Alzheimer's risk, new ideas to fight tau tangles, the BrightFocus-funded research of Nick Cochran, PhD, who is working to find out how an important gene for Alzheimer’s disease, called MAPT, is turned on in neurons, and more in the spring 2020 edition of Alzheimer's Disease Research Review.